Medication info
Gluris 4 mg Tablets (Glimepiride)

Gluris 4 mg Tablets (Glimepiride)

Prescription medicationTabletOral
Ingredient · strength
Glimepiride›4mg / 1 tablet
Manufacturer / importer
Korea Hutech Pharmaceutical Co., Ltd.
Appearance
Light blue rectangular tablets
Packaging
30 tablets/bottle, 300 tablets/bottle
Approval status
Active

MFDS item code 202000415 · Approved 2020.01.28 · Insurance code 649104750

Summary

Main use
Improvement of glycemic control in type 2 diabetes mellitus
Who takes it
Adults
Adult dose
Adjust the dose individually for each patient. Swallow without chewing with at least 1/2 cup of water. This medicine is administered orally once daily. It should be taken before breakfast or immediately before the first meal. It is very important not to skip a meal after taking this medicine. 1. Monotherapy 1) Initial dose and dose titration In patients who have not previously received medication, start treatment with glimepiride 1 mg once daily. If necessary, increase the dose by 1 mg at intervals of 1 ~ 2 weeks. In general, there is little additional benefit with doses above 4 mg, but some patients have achieved better metabolic control when the dose was increased to 6 mg (or 8 mg). If treatment with 4 mg once daily is unsuccessful, first consider switching to insulin therapy; otherwise, consider combination therapy with insulin or another oral antidiabetic medicine. 2) Subsequent dose adjustment As diabetes control improves during treatment, the need for this medicine may decrease. Therefore, dose reduction or discontinuation may be necessary to avoid hypoglycemia. Dose adjustment should also be considered if weight loss, lifestyle changes, or other factors that may increase the risk of hypoglycemia or hyperglycemia occur. 3) Switching from another oral blood glucose-lowering medicine to this medicine There is no exact dose equivalence between this medicine and other oral blood glucose-lowering medicines. When switching from another oral blood glucose-lowering medicine to this medicine, it is recommended to follow the instructions under Initial dose. That is, start with 1 mg once daily and adjust the dose at 1 ~ 2 week intervals. The potency and duration of action of the medicine previously administered should be taken into account. 4) Dose adjustment during treatment While taking this medicine, blood glucose and/or urine glucose levels should be measured regularly, and regular measurement of glycated hemoglobin (HbA1c) is also recommended. In general, hypoglycemia can be promptly controlled by immediately consuming sugar. Hypoglycemia may recur after treatment with a sulfonylurea, even if it was initially managed successfully. Therefore, patients should be monitored carefully. Severe hypoglycemia requires immediate medical treatment and follow-up, and hospitalization is sometimes required. 2. Combination therapy 1) Combination therapy with insulin Combination therapy with this medicine and insulin is used in patients with secondary failure and when fasting blood glucose (FBG) exceeds 150 mg/dL. Administer 8 mg of this medicine once daily with the first meal, and start insulin at a low dose, increasing it at approximately weekly intervals according to fasting blood glucose measurements. Once stabilized, capillary blood glucose should be monitored daily whenever possible. The insulin dose should be adjusted periodically while measuring blood glucose and glycated hemoglobin. 2) Combination therapy with metformin If the patient does not respond adequately to the maximum dose of this medicine, adding metformin may be considered. Published clinical information is available on combination therapy of metformin with other sulfonylureas, such as glibenclamide, glipizide, chlorpropamide, and tolbutamide. When this medicine is used in combination with metformin, the desired blood glucose level may be achieved by adjusting the dose of each medicine. However, efforts should be made to determine the minimum effective dose of each medicine for blood glucose control. There is a risk of hypoglycemia when this medicine is administered with metformin, and the risk may be increased. Appropriate caution should be exercised.

Ingredients

Manufacturer
Korea Hutech Pharmaceutical Co., Ltd.

Efficacy & effects

Improvement of glycemic control in type 2 diabetes mellitus

  • Abnormal blood sugar control in patients with type 2 diabetes
View approved original text

This medication is used in conjunction with dietary and exercise therapy to help control blood sugar levels in patients with type 2 diabetes. It can be used alone, but if blood sugar control is inadequate, it may be co-administered with oral hypoglycemic agents or insulin. Particularly, if the effect is insufficient when using sulfonylureas or metformin alone, this medication may be used in combination with metformin to improve blood sugar control. Therefore, it helps manage blood sugar more effectively in patients with type 2 diabetes.

How to take

Adult dose

Adjust the dose individually for each patient. Swallow without chewing with at least 1/2 cup of water. This medicine is administered orally once daily. It should be taken before breakfast or immediately before the first meal. It is very important not to skip a meal after taking this medicine. 1. Monotherapy 1) Initial dose and dose titration In patients who have not previously received medication, start treatment with glimepiride 1 mg once daily. If necessary, increase the dose by 1 mg at intervals of 1 ~ 2 weeks. In general, there is little additional benefit with doses above 4 mg, but some patients have achieved better metabolic control when the dose was increased to 6 mg (or 8 mg). If treatment with 4 mg once daily is unsuccessful, first consider switching to insulin therapy; otherwise, consider combination therapy with insulin or another oral antidiabetic medicine. 2) Subsequent dose adjustment As diabetes control improves during treatment, the need for this medicine may decrease. Therefore, dose reduction or discontinuation may be necessary to avoid hypoglycemia. Dose adjustment should also be considered if weight loss, lifestyle changes, or other factors that may increase the risk of hypoglycemia or hyperglycemia occur. 3) Switching from another oral blood glucose-lowering medicine to this medicine There is no exact dose equivalence between this medicine and other oral blood glucose-lowering medicines. When switching from another oral blood glucose-lowering medicine to this medicine, it is recommended to follow the instructions under Initial dose. That is, start with 1 mg once daily and adjust the dose at 1 ~ 2 week intervals. The potency and duration of action of the medicine previously administered should be taken into account. 4) Dose adjustment during treatment While taking this medicine, blood glucose and/or urine glucose levels should be measured regularly, and regular measurement of glycated hemoglobin (HbA1c) is also recommended. In general, hypoglycemia can be promptly controlled by immediately consuming sugar. Hypoglycemia may recur after treatment with a sulfonylurea, even if it was initially managed successfully. Therefore, patients should be monitored carefully. Severe hypoglycemia requires immediate medical treatment and follow-up, and hospitalization is sometimes required. 2. Combination therapy 1) Combination therapy with insulin Combination therapy with this medicine and insulin is used in patients with secondary failure and when fasting blood glucose (FBG) exceeds 150 mg/dL. Administer 8 mg of this medicine once daily with the first meal, and start insulin at a low dose, increasing it at approximately weekly intervals according to fasting blood glucose measurements. Once stabilized, capillary blood glucose should be monitored daily whenever possible. The insulin dose should be adjusted periodically while measuring blood glucose and glycated hemoglobin. 2) Combination therapy with metformin If the patient does not respond adequately to the maximum dose of this medicine, adding metformin may be considered. Published clinical information is available on combination therapy of metformin with other sulfonylureas, such as glibenclamide, glipizide, chlorpropamide, and tolbutamide. When this medicine is used in combination with metformin, the desired blood glucose level may be achieved by adjusting the dose of each medicine. However, efforts should be made to determine the minimum effective dose of each medicine for blood glucose control. There is a risk of hypoglycemia when this medicine is administered with metformin, and the risk may be increased. Appropriate caution should be exercised.

Precautions

This medication should not be used in patients with insulin-dependent diabetes, diabetic ketoacidosis, or in a comatose state. Additionally, patients who have had allergic reactions to this medication or its components should not receive it. For patients with severe liver or kidney dysfunction, it is recommended to switch to insulin therapy instead of using this medication. It is safest for women who are pregnant or may become pregnant and those who are breastfeeding not to take this medication. Insulin therapy may also be necessary for patients with severe infections, before and after surgery, or for those who have sustained significant injuries. Gastrointestinal disturbances such as diarrhea or vomiting may lead to insufficient nutrient absorption and an increased risk of hypoglycemia. Since this medication contains lactose, it should not be administered to patients with lactose intolerance or related genetic disorders. During the first week of starting this medication, there is a high risk of hypoglycemia, so blood sugar levels should be monitored closely. This risk is greater especially for those who are malnourished, eat irregularly or skip meals, or engage in excessive exercise. Patients who frequently consume alcohol or have reduced kidney or liver function, and the elderly, should also be cautious of hypoglycemia. Additionally, those with endocrine diseases such as thyroid disorders or adrenal insufficiency may find it difficult to control hypoglycemia. When taking other medications, it is essential to inform the healthcare provider or pharmacist as they may also affect blood sugar control. This medication has a blood sugar-lowering effect which can lead to hypoglycemia. Symptoms of hypoglycemia may include headache, severe hunger, nausea, fatigue, anxiety, confusion, dizziness, drowsiness, and decreased consciousness. In severe cases, seizures or comatose states can occur, and if symptoms appear, immediate intake of glucose or assistance from healthcare professionals is required. Initial initiation or dosage changes of this medication may temporarily cause side effects such as blurred vision or gastrointestinal disturbances. Serious side effects, such as liver dysfunction or a decrease in blood cell counts, can rarely occur; should you experience unusual symptoms, consult your healthcare provider immediately. Allergic reactions may manifest as skin rashes or respiratory difficulties; if symptoms such as hives arise, discontinue use immediately and seek medical attention. This medication is most effective for controlling blood sugar levels when combined with consistent dosing, dietary adjustments, exercise, and weight management. Quickly consuming glucose is important when hypoglycemia occurs, and patients should always carry sugary substances with them. Care should be taken when driving or operating machinery while using this medication. It may be difficult to control blood sugar during stressful situations, surgeries, or infections, so it is necessary to consult with healthcare professionals to adjust treatment methods accordingly. When taken with other medications, the effects of this medication may increase or decrease, so it is crucial to inform the physician about any medications currently being taken. Interactions can especially occur with beta-blockers, antibiotics, steroids, and anticoagulants. It is safest not to take this medication during pregnancy or breastfeeding, and insulin therapy should be initiated if necessary. In cases of overdose, severe hypoglycemia may occur; hence, immediate emergency measures such as inducing vomiting, stomach wash, or glucose injection are necessary. The safety and efficacy of this medication have not been established for children, and dosage adjustments may be required for the elderly due to reduced kidney function.

Side effects

  • Hypoglycemia
  • headache
  • severe hunger
  • nausea
  • vomiting
  • fatigue
  • sleep
  • sleep disorder
  • anxiety
  • aggression
Show 68 more
  • decreased concentration
  • decreased agility or energy
  • depression
  • confusion
  • language abnormalities
  • aphasia
  • visual disturbances
  • tremors
  • incomplete paralysis
  • perception abnormalities
  • dizziness
  • weakness
  • loss of self-control
  • temporary mental confusion
  • seizures
  • drowsiness
  • loss of consciousness
  • coma
  • shallow breathing
  • bradycardia
  • sweating
  • cold and clammy skin
  • tachycardia
  • hypertension
  • palpitations
  • angina
  • deep vein thrombosis
  • blurred vision
  • fullness in the upper abdomen
  • pressure sensation
  • abdominal pain
  • diarrhea
  • elevated liver enzymes
  • liver dysfunction
  • bile secretion disorder
  • jaundice
  • hepatitis
  • thrombocytopenia
  • leukopenia
  • hemolytic anemia
  • erythrocytopenia
  • neutropenia
  • agranulocytosis
  • pancytopenia
  • itching
  • urticaria
  • rash
  • shortness of breath
  • hypotension
  • shock
  • anaphylaxis
  • angioedema
  • Stevens-Johnson syndrome
  • allergic vasculitis
  • phototoxic skin reactions
  • serum sodium concentration decrease
  • taste disturbance
  • hair loss
  • weight gain
  • dizziness
  • liver dysfunction
  • abdominal pain
  • arthralgia
  • dyspepsia
  • facial swelling
  • erectile dysfunction
  • flushing of the face
  • gastritis

Not everyone experiences these, and they can vary from person to person.

Storage

This medication should be stored in a tightly closed container to protect it from air and moisture. It is recommended to maintain a room temperature between 1 degree and 30 degrees Celsius for storage.

Appearance and packaging

Appearance

Light blue rectangular tablets

Package unit

30 tablets/bottle, 300 tablets/bottle

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.